글로벌 풍진 치료 시장 – 2029년까지의 산업 동향 및 예측

풍진 치료 시장 분석 및 규모

글로벌 풍진 치료 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 풍진 발생 증가는 공기를 통한 토가바이러스의 높은 전염 능력의 직접적인 결과입니다. 풍진 감염은 일반적으로 어린이와 성인에게 영향을 미칩니다. 이 질병은 임산부에게 심각한 영향을 미쳐 태아 사망이나 선천적 결함으로 이어집니다. 세계보건기구 기록에 따르면 194개국 중 168개국이 건강 프로그램에 풍진 백신을 도입했으며, 2018년 12월 현재 전 세계 적용률은 약 69%였습니다. COVID-19도 시장 성장에 큰 영향을 미쳤습니다.

 Data Bridge Market Research는 2022-2029년 예측 기간 동안 풍진 치료 시장의 성장률을 분석합니다. 풍진 치료 시장의 예상 CAGR은 언급된 예측 기간 동안 약 6.50%인 경향이 있습니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

풍진 치료 시장 범위 및 세분화

Market Definition

Rubella is also known as German measles and is a contagious viral infection caused by rubivirus infection. Rubella is typically characterized by rash, fever and eye redness and is usually found in children. It spreads through air or in contact with the infected person. Rubella infection commonly affects children and adults. The infection has severe implications in pregnant women, that can lead to fetal death or congenital defects. 

Global Rubella Treatment Market Dynamics

Drivers

• Increased Demand of Diagnostic Tests

Diagnostic tests such as flow cytometry, monoclonal antibodies, immunoassays, latex slide agglutination test, serological testing, and clinical evaluation are boosting the growth of the market. These tests are characteristically prescribed for pregnant women and also for women planning to conceive. These tests may also be conducted for babies having congenital defects. Thus, it boosts the market growth.

• Growing Government Initiatives 

Numerous government initiatives relating to research and development of advanced diagnostic techniques in developing countries such as China and India are performed, which is anticipated to boost the market growth in the near future. This boost the growth of the market.

Opportunities

• Rising Demand of MMR Vaccines

Growing demand for measles, mumps and rubella (MMR) vaccines for the protection of children against rubella and the launch of advanced point-of-care diagnostic technologies such as BioPlex 2200 MMRV (varicella zoster, rubella, mumps and measles virus) by Bio Rad Laboratories are moreover creating growth opportunities for the global rubella market.

• Increasing Demand for Retail Pharmacies

The rise in the number of perinatal infections therapeutics delivered through retail pharmacies and more retail pharmacies in developed countries create opportunities for the market expansion. Additionally, patients choose retail pharmacies over other types for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

• Lack of skilled professionals

The lack of appropriate healthcare professionals who cannot treat the patients with suitable treatments could curb the growth of the global rubella treatment market over a forecast period.

• Unavailability of Vaccinations

There is wide unavailability of vaccines that is hampering the market growth. Vaccination for rubella are not available in these regions. It was recorded that Thailand, Timor Leste, Macedonia, Tajikistan, and Syria are accounted for biggest number of rubella infection cases as of 2013 but there was lack of vaccines and medicines that hampered the market growth.

This global rubella treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global rubella treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Rubella Treatment Market Scope

The global rubella treatment market is segmented on the basis of drugs, vaccines, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drugs

• Paracetamol
• Ibuprofen
• Aspirin
• Others

Treatment

• Medication
• Vaccinations

Vaccines

• Proquad
• M-M-R II
• Others

Route of Administration

• Oral
• Injectable

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Rubella Treatment Market Regional Analysis/Insights

The global rubella treatment market is analyzed and market size insights and trends are provided by drugs, vaccines, treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global rubella treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing positive growth for global rubella treatment market throughout the forecasted period due to the rising adoption of modern healthcare technologies and initiative the federal government took to promote awareness.

아시아 태평양 지역은 의료 인프라 개발 지출 증가, 미활용 기회 존재, 개인의 가처분소득 증가 등으로 시장을 장악하고 있습니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 또한 글로벌 브랜드의 존재와 가용성, 그리고 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

경쟁 환경 및 글로벌 풍진 치료 시장 점유율 분석

글로벌 풍진 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 글로벌 풍진 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 풍진 치료 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 머크 KGaA(독일)
• 노바티스 AG(미국)
• 마일런 NV(미국)
• Teva Pharmaceutical Industries Ltd. (이스라엘)
• 사노피(프랑스)
• 노바티스 AG(스위스)
• Sun Pharmaceutical Industries Ltd. (인도)
• Aurobindo Pharma(인도)
• GSK plc (영국)
• F. 호프만-라 로슈 유한회사(스위스)
• 아스트라제네카(영국)
• 릴리(미국)

SKU-47806